-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Celldex Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2017 to Q1 2024.
- Celldex Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$40.6M, a 42.2% decline year-over-year.
- Celldex Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$158M, a 47.1% decline from 2023.
- Celldex Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$107M, a 3.43% decline from 2022.
- Celldex Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$104M, a 70.3% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)